Liver enzyme elevation in patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors: a single-center historical cohort study

BACKGROUND/AIMS: Tumor necrosis factor inhibitors (TNFi) have been known to induce liver enzyme elevation, sometimes associated with viral reactivation or toxic hepatitis. We evaluated the incidence and risk factors of TNFi-associated liver enzyme elevation in Korean ankylosing spondylitis (AS) pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Su Jin, Oh, Ji Seon, Hong, Seokchan, Lee, Chang-Keun, Yoo, Bin, Kim, Yong-Gil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214361/
https://www.ncbi.nlm.nih.gov/pubmed/31870134
http://dx.doi.org/10.3904/kjim.2018.407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214361/
https://www.ncbi.nlm.nih.gov/pubmed/31870134
http://dx.doi.org/10.3904/kjim.2018.407

Ejemplares similares